TCF7L2 rs7903146-macronutrient interaction in obese individuals' responses to a 10-wk randomized hypoenergetic diet

American Journal of Clinical Nutrition

Volumn 91, Issue 2, 2010, Pages 472-479

  Grau, Katrine ^a,b,c   Cauchi, Stephane ^d   Holst, Claus ^a   Astrup, Arne ^c   Martinez, J Alfredo ^e   Saris, Wim H M ^f   Blaak, Ellen E ^f   Oppert, Jean Michel ^g   Arner, Peter ^h   Rössner, Stephan ^h   Macdonald, Ian A ⁱ   Klimcakova, Eva ^j   Langin, Dominique ^k,l,m   Pedersen, Oluf ^n,o,p,q   Froguel, Philippe ^b   Sørensen, Thorkild I A ^a  

^a Centre for Health and Society   (Denmark)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d CNRS   (France)

^e UNIVERSITY OF NAVARRA   (Spain)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g HÔTEL DIEU   (France)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^j CHARLES UNIVERSITY   (Czech Republic)

^k INSERM   (France)

^l UNIVERSITÉ DE TOULOUSE   (France)

^m TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁿ STENO DIABETES CENTER   (Denmark)

^o HAGEDORN RESEARCH INSTITUTE   (Denmark)

^p UNIVERSITY OF COPENHAGEN   (Denmark)

^q AARHUS UNIVERSITY   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FAT; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; ALLELE; ARTICLE; BODY WEIGHT; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; ENERGY EXPENDITURE; FAT INTAKE; GENE INTERACTION; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; OBESITY; OXIDATION; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BASAL METABOLISM; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY FATS; DNA; FEMALE; GENOTYPE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TCF TRANSCRIPTION FACTORS;

EID: 75649151721     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.27947     Document Type: Article

References (37)

1. Petersen M, Taylor MA, Saris WH, et al. Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content. Int J Obes (Lond) 2006;30:552-60.
2. Sørensen TIA, Boutin P, Taylor MA, et al. Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets. PLoS Clin Trials 2006;1:e12.
3. Grau K, Hansen T, Holst C et al. Macronutrient-specific effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes (Lond) 2009;33:1227-34.
4. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-3.
5. Cauchi S, El AY, Choquet H, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 2007;85:777-82.
6. Groves CJ, Zeggini E, Minton J, et al. Association analysis of 6,736 U. K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006;55:2640-4.
7. Helgason A, Palsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39:218-25.
8. Weedon MN. The importance of TCF7L2. Diabet Med 2007;24:1062-6.
9. Kimber CH, Doney AS, Pearson ER, et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 2007;50:1186-91.
10. Cauchi S, Nead KT, Choquet H, et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 2008;9:45.
11. Cauchi S, Choquet H, Gutierrez-Aguilar R, et al. Effects of TCF7L2 polymorphisms on obesity in European populations. Obesity (Silver Spring) 2008;16:476-82.
12. Goossens GH, Petersen L, Blaak EE, et al. Several obesity- and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: the NUGENOB study. Int J Obes (Lond) 2009;33:669-79.
13. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005;280:1457-64.
14. Schafer SA, Tschritter O, Machicao F, et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 2007;50: 2443-50.
15. Pilgaard K, Jensen CB, Schou JH, et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 2009;52:1298-307.
16. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998;101: 515-20.
17. Verdich C, Flint A, Gutzwiller JP, et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 2001;86:4382-9.
18. Azuma K, Radikova Z, Mancino J, et al. Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93:459-64.
19. Boschmann M, Engeli S, Dobberstein K, et al. Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J Clin Endocrinol Metab 2009;94:846-52.
20. Gao H, Wang X, Zhang Z, et al. GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine 2007;32:90-5.
21. Eller LK, Ainslie PN, Poulin MJ, Reimer RA. Differential responses of circulating amylin to high-fat vs. high-carbohydrate meal in healthy men. Clin Endocrinol (Oxf) 2008;68:890-7.
22. Paniagua JA, de la Sacristana AG, Sanchez E, et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulinresistant subjects. J Am Coll Nutr 2007;26:434-44.
23. Verdich C, Madsen JL, Toubro S, Buemann B, Holst JJ, Astrup A. Effect of obesity and major weight reduction on gastric emptying. Int J Obes Relat Metab Disord 2000;24:899-905.
24. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949;109:1-9.
25. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-34.
26. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
27. Emoto M, Nishizawa Y, Maekawa K, et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999;22:818-22.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
29. Gauderman WJ, Morrison JM. QUANTO 1.2: a computer program for power and sample size calculations for genetic-epidemiology studies. Available from: http://hydra.usc.edu/gxe (cited 2006).
30. Damcott CM, Pollin TI, Reinhart LJ, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006;55:2654-9.
31. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006;355:241-50.
32. Loos RJ, Franks PW, Francis RW, et al. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes 2007;56:1943-7.
33. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007;117:2155-63.
34. Fisher E, Boeing H, Fritsche A, Doering F, Joost HG, Schulze MB. Whole-grain consumption and transcription factor-7-like 2 (TCF7L2) rs7903146: gene-diet interaction in modulating type 2 diabetes risk. Br J Nutr 2009;101:478-81.
35. Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am J Clin Nutr 2009;89:1256-62.
36. Warodomwichit D, Arnett DK, Kabagambe EK, et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. J Nutr 2009;139:439-46.
37. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57.